Increased HSP90α concentrations in patients with arterial hypertension may be a compensatory mechanism for impaired nitric oxide bioavailability [67], confirming that HSP90α can serve as an early marker of hypertension-related endothelial injury [67]. This evidence concerns the gene HSP90AA1 and hypertensive disorder.